Treatments for elderly CLL patients

Assessing psycho-oncology

Treatment barriers for elderly patients

Battling rare cancers in Europe - access and ethics

Access to new tailored cancer therapies and reliable patient information - the challenges

Ethical considerations surrounding cancer in the elderly and the pros and cons of web-based resources

Classification of thymic tumours

Role of predictive markers in personalised cancer treatment

Treatment options for low grade neuroendocrine lung carcinoma

Optimal care for patients with stage I-III non-small cell lung cancer

Significance of the ALK Marker in non-smoker lung cancer patients

State of play in thoracic oncology